Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-05-17 @ 1:47 PM
Study NCT ID:
NCT05194735
Status:
TERMINATED
Last Update Posted:
2025-11-07
First Post:
2021-12-06
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
Sponsor:
Alaunos Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TCR001-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None